The number of years that early stage endometrial cancer can live is usually related to the patient’s age of consultation and the severity of the disease, etc. Among gynecological malignancies, the treatment effect is better and the survival rate is about 70%. Endometrial cancer is a common malignant tumor in women, with characteristics of slow growth, late metastasis and obvious early symptoms, etc. The diagnosis method is relatively easy, and most patients are in clinical stage I when they are diagnosed. There are significant differences in survival time depending on the age of patients at the time of diagnosis. The survival rate of younger patients is higher because they are diagnosed at an early stage, have a higher degree of differentiation, and often do not have myometrial involvement. In contrast, older patients with endometrial cancer are often of specific pathological type or hypodifferentiated adenocarcinoma, often with ectopic lesions, which are more malignant and relatively difficult to treat, and their survival rate will be affected to some extent. Therefore, it is recommended that patients with early-stage endometrial cancer promptly visit the gynecology department of a hospital and adopt a comprehensive treatment method such as surgery, radiotherapy, chemotherapy and progesterone, in order to improve survival rate and quality of life.